Follow our twitter: @ERINHA_RI

You can contact us here

Access to our intranet here

Download our portfolio here

News

Now, more than ever, biomedical research needs to be done with speed, efficiency, and high-quality standards in order to help patients effectively fight diseases like COVID-19. But too often, researchers find themselves without enough time, resources, access to facilities, or knowledge of recommended standards to successfully complete their research. That’s exactly where European Life Science […]

Read more

Trailhead Biosystems Inc. in partnership with ERINHA and our member, The Rega Institute of Medical research of KU Leuven, found out a triple drug combination which shown synergistic efficacy against Sars-CoV-2. The Rega Institute runs CAPS-IT, one of the most advanced high containment testing facilities in the world and perhaps the only laboratory that can safely and quickly […]

Read more

ERINHA launched a special SARS-Cov-2/COVID-19 call for free of charge Transnational Access (TNA) to its cutting-edge high containment and complementary facilities. ERINHA SARS-CoV-2/COVID-19 call for free of charge Transnational Access has been launched A special call for proposals fully dedicated to COVID-19 / SARS-CoV-2 research has been launched by ERINHA. With the support of the […]

Read more

ERINHA Members – leading European high-containment facilities and world level experts – are highly involved both in diagnostics and research activities to tackle COVID-19 by developing and testing diagnostics, therapeutics and vaccines. A number of national, European, and international funding organizations launched call to advance research in short timelines to address the current SARS CoV […]

Read more

Spotlight on ERINHA-Advance member, National Institute of Infectious Diseases (INMI) of Italy involved in CONVAT project. CONVAT consortium got funding from the European Commission emergency call. It is a cooperation project between Spain, Italy and France to develop a point-of-care platform, for rapid diagnosis and monitoring of coronavirus, directly from the patient’s sample and without […]

Read more

ERINHA is involved in EUROCOVID project consortium recently submitted to IMI call “Development of therapeutics and diagnostics combatting coronavirus infections”. EUROCOVID EUROpean COoperation for anti-VIral Drug discovery and preparedness for current and emerging coronavirus outbreaks”creates a European, multidisciplinary world-class network for the development of pan-coronavirus antivirals that will rapidly respond to the current SARS-CoV 2 outbreak […]

Read more

ERINHA welcomes its newest Member: The Rega Institute for Medical Research of the Katholieke Universiteit Leuven (KU Leuven), Belgium The Rega Institute for Medical Research of KU Leuven joined ERINHA infrastructure in February 2020. The institute has a long-standing experience and expertise in the discovery and development of antiviral drugs. Notably, in collaboration with the […]

Read more

“Rapid therapy development through Open Coronavirus Vaccine Platform” – Spotlight on ERINHA Swedish node research activities OPENCORONA consortium has been awarded €3m funding by the European Commission Horizon 2020 emergency call to support research and development against the COVID-19 outbreak, aiming to develop a vaccine for the novel virus. The Consortium is led by Karolinska Institute, […]

Read more

CORBEL: A new website, lifescience-ri.eu, brings together the vast services of 13 Life Science Research Infrastructures.This website aims to be a common source of comprehensive information about the 13 European LS RIs, their activities, offers, news and funding opportunities. Their joint service catalogue allows to identify which RI might be able to meet a certain need. […]

Read more